News and Trends on Pharma Industry Production & Manufacturing

Samsung Biologics Launches CHF 1.46B Acquisition of PolyPeptide to Scale Peptide Capabilities

Yuvraj — Mon, 20 Jul 2026 13:22:51 +0000

The global biopharmaceutical contract manufacturing sector is undergoing a rapid transition toward complex modalities as drug developers prioritize specialized treatments for metabolic and chronic conditions. In a major move to consolidate its position within the high-growth peptide market, Samsung Biologics has announced an all-cash public tender offer to acquire 100% of PolyPeptide Group AG. Valued […]

The post Samsung Biologics Launches CHF 1.46B Acquisition of PolyPeptide to Scale Peptide Capabilities first appeared on World Pharma Today.

FDA Proposes New Rule for Drug Manufacturing Registration

Yuvraj — Tue, 14 Jul 2026 10:11:26 +0000

The modernization of regulatory frameworks is becoming essential to support the pharmaceutical industry’s transition toward advanced production models and to ensure the resilience of global supply chains. As innovative manufacturing technologies emerge, traditional oversight mechanisms must evolve to maintain safety standards while reducing unnecessary complexity for producers. In a significant move to align regulations with […]

The post FDA Proposes New Rule for Drug Manufacturing Registration first appeared on World Pharma Today.

Why Modular GMP Facilities are Scaling Faster Than Ever

Yuvraj — Thu, 09 Jul 2026 06:16:22 +0000

The development of a new pharmaceutical manufacturing site has traditionally been a multi-year undertaking, involving a complex sequence of design, construction, and rigorous validation. For companies operating in the fast-moving cell and gene therapy sector, this traditional timeline is often too slow to meet the needs of clinical trials or the demands of a first-to-market […]

The post Why Modular GMP Facilities are Scaling Faster Than Ever first appeared on World Pharma Today.

Why Living Drugs Need a New Generation of Fill-Finish

Yuvraj — Thu, 09 Jul 2026 06:05:02 +0000

The final stages of the pharmaceutical manufacturing process, where the therapeutic product is filled into its primary container and prepared for delivery, have long been dominated by high-speed lines designed for millions of identical doses. However, the emergence of advanced biologics, often referred to as “living drugs,” has rendered these traditional methods obsolete. Cell and […]

The post Why Living Drugs Need a New Generation of Fill-Finish first appeared on World Pharma Today.

How CAR-T Manufacturing Is Breaking the 14-Day Barrier

Yuvraj — Thu, 09 Jul 2026 05:55:39 +0000

The development of Chimeric Antigen Receptor T-cell (CAR-T) therapy has provided a new and powerful tool for the treatment of hematological malignancies, offering hope to patients who have exhausted all other therapeutic options. However, the logistical and technical challenge of producing these personalized treatments remains a significant hurdle. For many years, the standard manufacturing cycle […]

The post How CAR-T Manufacturing Is Breaking the 14-Day Barrier first appeared on World Pharma Today.

Vector Manufacturing Meets Rising Gene Therapy Demand

Yuvraj — Thu, 09 Jul 2026 05:48:08 +0000

The rapid expansion of the gene therapy sector has created a critical challenge in the production of viral vectors, the specialized vehicles used to deliver genetic material to target cells. As more therapies move from early-phase clinical trials toward large-scale commercialization, the demand for Adeno-Associated Virus (AAV) and lentiviral vectors has reached unprecedented levels. Historically, […]

The post Vector Manufacturing Meets Rising Gene Therapy Demand first appeared on World Pharma Today.

The Race to Real-Time Cell Therapy Manufacturing

Yuvraj — Thu, 09 Jul 2026 05:18:43 +0000

The logistical and technical complexity of producing personalized medicines has reached a point where traditional batch testing methods are no longer sufficient to meet the needs of a growing patient population. In conventional pharmaceutical production, a product is manufactured and then subjected to a series of quality control tests that can take several days or […]

The post The Race to Real-Time Cell Therapy Manufacturing first appeared on World Pharma Today.

Study Identifies Tiered Manufacturing in Global Pharmaceutical Markets

Yuvraj — Thu, 09 Jul 2026 05:04:21 +0000

A new research project from the Johns Hopkins Bloomberg School of Public Health has identified a pharmaceutical industry practice that could be a significant factor in global health disparities. Published in PLOS Global Public Health on July 07, 2026, the study introduces and defines the concept of tiered manufacturing, which refers to the production of […]

The post Study Identifies Tiered Manufacturing in Global Pharmaceutical Markets first appeared on World Pharma Today.

Shilpa Biologicals Launches Integrated ADC Production Site in India

Yuvraj — Wed, 01 Jul 2026 06:02:32 +0000

Shilpa Biologicals Ltd, a subsidiary of Shilpa Medicare Ltd, has officially commissioned an advanced integrated Antibody–Drug Conjugate (ADC) GMP manufacturing site in Dharwad. Announced on 25 June 2026, the facility was specifically engineered to satisfy the rigorous global regulatory standards of the US FDA, EMA, and other prominent health authorities. This ADC manufacturing facility is […]

The post Shilpa Biologicals Launches Integrated ADC Production Site in India first appeared on World Pharma Today.

CPHI Milan 2026 Unveils Dedicated Innovation Hubs for Pharma Manufacturing

Yuvraj — Wed, 01 Jul 2026 05:42:24 +0000

CPHI Milan 2026, recognized as a premier global gathering for the pharmaceutical industry, has announced the introduction of four new specialist zones for pharma at its upcoming event. Scheduled for October 6-8, 2026, at the Fiera Milan exhibition centre in Rho, Italy, these specialized areas will focus on AI & Tech, Cold Chain & Logistics, […]

The post CPHI Milan 2026 Unveils Dedicated Innovation Hubs for Pharma Manufacturing first appeared on World Pharma Today.